- Home
- BLDE vs AMRN Comparison
BLDE vs AMRN Comparison
Compare BLDE & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- AMRN
- Stock Information
- Founded
- BLDE 2014
- AMRN 1989
- Country
- BLDE United States
- AMRN Ireland
- Employees
- BLDE N/A
- AMRN N/A
- Industry
- BLDE Aerospace
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- BLDE Consumer Discretionary
- AMRN Health Care
- Exchange
- BLDE Nasdaq
- AMRN Nasdaq
- Market Cap
- BLDE 285.2M
- AMRN 216.0M
- IPO Year
- BLDE N/A
- AMRN 1993
- Fundamental
- Price
- BLDE $4.06
- AMRN $16.51
- Analyst Decision
- BLDE Strong Buy
- AMRN Strong Sell
- Analyst Count
- BLDE 2
- AMRN 1
- Target Price
- BLDE $6.25
- AMRN $12.00
- AVG Volume (30 Days)
- BLDE 833.2K
- AMRN 180.2K
- Earning Date
- BLDE 08-06-2025
- AMRN 07-30-2025
- Dividend Yield
- BLDE N/A
- AMRN N/A
- EPS Growth
- BLDE N/A
- AMRN N/A
- EPS
- BLDE N/A
- AMRN N/A
- Revenue
- BLDE $251,485,000.00
- AMRN $214,112,000.00
- Revenue This Year
- BLDE $5.58
- AMRN N/A
- Revenue Next Year
- BLDE $8.56
- AMRN $7.88
- P/E Ratio
- BLDE N/A
- AMRN N/A
- Revenue Growth
- BLDE 8.67
- AMRN N/A
- 52 Week Low
- BLDE $2.35
- AMRN $7.08
- 52 Week High
- BLDE $5.17
- AMRN $17.18
- Technical
- Relative Strength Index (RSI)
- BLDE 59.83
- AMRN 71.62
- Support Level
- BLDE $3.57
- AMRN $12.30
- Resistance Level
- BLDE $3.90
- AMRN $17.18
- Average True Range (ATR)
- BLDE 0.22
- AMRN 1.09
- MACD
- BLDE -0.03
- AMRN 0.26
- Stochastic Oscillator
- BLDE 56.25
- AMRN 73.61
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.